Novartis Contract Manufacturing Capacity Update July 2025: Large Molecule Drug Substance

Novartis Contract Manufacturing is a global contract manufacturing player in the biotech, small molecules and cell & gene therapy offering world class manufacturing services in the Novartis state of art facilities across USA, Europe and Singapore. We are committed to the highest quality standards. We offer end-to-end manufacturing solutions in Mammalian, Microbial, Cell and Gene Therapy, xRNA, Small Molecules & Fill/Finish.

The presentation introduces biologics CDMO solutions and capacity offered by Novartis Contract Manufacturing. We discuss our capabilities in mammalian cell culture manufacturing and microbial fermentation.